Based on 3 analysts offering 12 month price targets for Terns Pharmaceuticals Inc
Min Forecast
$7.44+0.54%
Avg Forecast
$14.15+91.18%
Max Forecast
$20.00+170.27%
Should I buy or sell TERN stock?
Based on 3 analysts offering ratings for Terns Pharmaceuticals Inc.
Buy
Strong Buy
1 analysts 33.33%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although TERN's forecast from analysts indicates a "Buy", our proven Zen Rating quant model rates TERN as a "Sell". Stocks with a Zen Rating of Sell have had an average return of -4.50% per year. Learn More
Be the first to know when Wall Street analysts revise their TERN stock forecasts and price targets.
Is Terns Pharmaceuticals Stock a good buy in 2025, according to Wall Street analysts?
The consensus among 3 Wall Street analysts covering (NASDAQ: TERN) stock is to Buy TERN stock.
Out of 3 analysts, 1 (33.33%) are recommending TERN as a Strong Buy, 1 (33.33%) are recommending TERN as a Buy, 1 (33.33%) are recommending TERN as a Hold, 0 (0%) are recommending TERN as a Sell, and 0 (0%) are recommending TERN as a Strong Sell.
According to 3 Wall Street analysts that have issued a 1 year TERN price target, the average TERN price target is $14.15, with the highest TERN stock price forecast at $20.00 and the lowest TERN stock price forecast at $7.44.
On average, Wall Street analysts predict that Terns Pharmaceuticals's share price could reach $14.15 by Sep 17, 2026. The average Terns Pharmaceuticals stock price prediction forecasts a potential upside of 91.18% from the current TERN share price of $7.40.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.